back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 14:21 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Older filings | ||||||
| Filed 2025-12-22 13:04 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2025-12-19 20:44 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2026-03-10 17:15 Tx date 2026-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-17,080
-1,525 vol $11.20 each |
0 | |
| Filed 2025-12-22 13:04 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
10,000 | |
| Filed 2025-12-19 20:44 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2025-12-19 20:45 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$172,600
+20,000 vol $8.63 each |
222,500 | |
| Filed 2025-12-19 20:44 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
10,000 | |
| Filed 2025-12-19 20:44 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-03 12:31 Tx date 2025-11-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-12,500 vol $8.00 each |
202,500 | |
| Filed 2025-09-24 17:04 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$18,496
+3,363 vol $5.50 each |
228,228 | |
| Filed 2025-08-11 19:33 Tx date 2025-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,500
+25,000 vol $5.42 each |
215,000 | |
| Filed 2025-04-14 14:11 Tx date 2025-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-200,000
-25,000 vol $8.00 each |
190,000 | |
| Filed 2025-03-27 14:12 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,300
+45,000 vol $5.14 each |
215,000 | |
| Filed 2024-09-11 11:59 Tx date 2024-09-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,044
+400 vol $2.61 each |
224,865 | |
| Filed 2024-09-11 11:57 Tx date 2024-09-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,095
+1,500 vol $2.73 each |
224,465 | |
| Filed 2024-06-17 16:09 Tx date 2024-06-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,926
+1,100 vol $2.66 each |
222,965 | |
| Filed 2024-06-12 12:08 Tx date 2024-06-11 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,248
+800 vol $2.81 each |
221,865 | |
| Filed 2024-06-09 21:38 Tx date 2024-06-07 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,730
+1,000 vol $2.73 each |
221,065 | |
| Filed 2024-05-22 23:09 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
170,000 | |